FEB 23, 2017 06:00 AM PST

Obtaining Samples for Precision Medicine Studies: An Outsider's Perspective

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Chief Commercial Officer, Omniseq
    Biography
      Matt Klusas serves as Chief Commercial Officer at OmniSeq. He leads the OmniSeq sales, marketing, business development, and customer service functions. Prior to joining OmniSeq, Matt was most recently at Thermo Fisher Scientific, where he led a business focusing on large scale deployments of genetic analysis technologies, including next generation DNA sequencing, Capillary Electrophoresis sequencing, qPCR, and other technologies. Prior to Thermo Fisher Scientific, Matt held management roles at the American Type Culture Collection (ATCC), Life Technologies, and McKinsey & Co. Matt is published in the Journal of Commercial Biotechnology, the McKinsey Quarterly, and the Credit Union Journal. In 2015, Illinois State University selected him the Young Alumni of the Year. He received an MSc in Economic History from the London School of Economics and a BS in Communication from the Illinois State University. He also studied at Magdalen College, University of Oxford.

    Abstract:

    Best practices for developing precision medicine diagnostics can include completing a retrospective analysis.  Obtaining enough samples to have a statistically significant study typically requires going beyond an initial institution.  There are a multitude of impediments that can frustrate the ability to rapidly identify and obtain samples.  This presentation will review these impediments by segmenting institutions into three segments: major academic medical centers, biobanks, community practices and mid-tier cancer centers.  Within each of these segments, the presentation will discuss the typical impediments.  The presentation will close with some recommendations for improving the process for both requestors and providers.      


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    Loading Comments...
    Show Resources